Valve replacement | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Posts Tagged ‘Valve replacement’

Investigational Devices: Edwards Sapien Transcatheter Aortic Heart Valve Replacement Transfemoral Deployment

Posted in Frontiers in Cardiology and Cardiovascular Disorders, Medical Devices R&D and Inventions, Valves & Tools, tagged Aortic valve, Aortic valve stenosis, Cardiac surgery, Edwards SAPIEN, Heart valve, Valve replacement on June 10, 2012| 7 Comments »

Reporter: Aviva Lev-Ari, PhD, RN

Cohort A of the PARTNER (Placement of AoRTic traNscatheterER valves) Trial is designed for patients with severe calcific aortic stenosis who are considered to be high-risk for conventional open-chest valve replacement due to the risk surgery might pose to them. These patients may be eligible to participate in a new, investigational transcatheter valve replacement procedure that is performed without

http://www.edwards.com/products/investigationaldevices/Pages/SapienTHV.aspx

Read Full Post »

Investigational Devices: Edwards Sapien Transcatheter Aortic Valve Transapical Deployment

Posted in Frontiers in Cardiology and Cardiovascular Disorders, Medical Devices R&D and Inventions, Valves & Tools, tagged Aortic valve, Aortic valve stenosis, calcific aortic stenosis, Cardiac surgery, Edwards SAPIEN, health, Heart valve, Investigational device, Medtronic, Valve replacement on June 4, 2012| 8 Comments »

Reporter: Aviva Lev-Ari, PhD, RN

The Edwards SAPIEN transcatheter heart valve is an investigational device which is placed either through a transfemoral (RetroFlex 3 Transfemoral Delivery System) or transapical (Ascendra Transapical Delivery System) approach. The Edwards SAPIEN valve is being evaluated in the treatment of patients with severe calcific aortic stenosis who are considered to be high-risk for conventional open-heart valve replacement surgery.Cohort A of the PARTNER (Placement of AoRTic traNscatheterER valves) Trial is designed for patients with severe calcific aortic stenosis who are considered to be high-risk for conventional open-chest valve replacement due to the risk surgery might pose to them. These patients may be eligible to participate in a new, investigational transcatheter valve replacement procedure that is performed without

http://www.edwards.com/products/investigationaldevices/Pages/SapienTHV.aspx